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Summary 
Antigen-specific B cell responses to mucosally delivered proteins are dependent upon CD4-positive 
T helper (Th) cells, and the frequency of Thl and Th2 cell responses after oral immunization 
may determine the level and isotype of mucosal antibody responses. We have used a protein-based 
vaccine, tetanus toxoid (TT), together with the mucosal adjuvant cholera toxin (CT), for oral 
immunization of mice to study the nature of antigen-specific  Th cell subsets induced in Peyer's 
patches (PP) of the gastrointestinal (GI) tract and in the spleen (SP) during peak antibody responses. 
Mice orally immunized with TT and CT responded with antigen-specific secretory immunoglobulin 
A (S-IgA) antibodies in the GI tract, and with both IgG and IgA antibody responses in serum. 
PP and SP CD4 + T  cells from mice orally immunized with TT plus CT were cultured with 
antigen-coated latex microspheres for induction of proliferative  responses and for enumeration 
of cytokine producing CD4 + T  cells. Interestingly, both PP and SP CD4 + T  cell cultures 
showed increased numbers of IL-4- and IL-5 (Th2-type)-producing, spot-forming cells (SFCs) 
after 21 d of immunization, while essentially no intefferon-3~ (IFN-'y) or IL-2 (Thl-type) SFCs 
were noted. Cytokine-spedfic Northern blots and RT-PCR also revealed that significant  IL-4 
and IL-5 mRNA levels, but not IFN-3, or IL-2 mRNA, were present in CD4 + T cells isolated 
from antigen-stimulated cultures. However, systemic immunization with TT and CT induced 
antigen-specific IgG and IgM but not IgA antibodies in serum. Further, both IL-2- and IFN-3,- 
producing Thl-type cells as well as IL-4- and IL-5-secreting Th2-type cells were generated in 
SP. Our results show that oral immunization with TT and the mucosal adjuvant CT selectively 
induced antigen-specific Th2-type responses which may represent the major helper cell phenotype 
involved in mucosal IgA responses  in the GI tract. 
S 
tudies of cytokine production by murine Th cell clones 
have provided direct evidence for the existence of at least 
two different Th subsets that may have a common precursor 
(Th0) (reviewed in references 1-4). Thl cells selectively pro- 
duce IL-2, IFN-3', and TNF-3, whereas Th2 cells are unique 
in the production oflL-4, IL-5, IL-6, and IL-10 (1-4). These 
distinct cytokine profiles contribute to pronounced differences 
in Th cell function. The Thl cell subset is preferentially in- 
volved in cell-mediated immunity, while Th2 cells are most 
effective in the regulation and support of B cell responses 
(1-4). In the case of IgA responses, IL-5 and IL-6 have been 
shown to induce committed surface IgA + B cells to secrete 
IgA (5-10). 
It  has  also  been  established  that  certain  antigens  and 
microbial infections elicit responses predominantly associated 
with one of the two Th cell subsets (11-14). Downregula- 
tion of Thl cytokine production accompanied by the induc- 
tion of Th2 cell responses is a characteristic  of the immune 
response to the parasitic helminth, Schistosoma raansoni (11). 
Furthermore, it was shown that the murine nematode Trichuris 
muris induced predominantly IFN-~/-secreting Thl-type cells 
in susceptible mouse strains, while IL-4- and IL-5-producing 
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routes of immunization may also induce different subsets of 
Th ceils which may in turn influence the isotype of B cell 
responses.  Oral immunization of mice with SRBC resulted 
in predominantly IL-5-produeing, Th2-type cells in both 
Peyer's patches (pp)t and spleen (SP), while higher frequen- 
cies of IFN-3,-producing Thl-type cells occurred in SP of 
mice given antigen by the systemic route (15). Furthermore, 
it has been shown that higher numbers of IL-5-producing, 
Th2-tyl~ cells, when compared with IFN-7-producing T cells, 
were seen in mucosal effector tissues, i.e., the lamina propria 
(LP) of the gastrointestinal  (GI) tract and in the salivary glands 
(16, 17). 
Cholera toxin (CT), a protein exotoxin produced by Vibrio 
cholerae, is a multi-subunit molecule composed of two struc- 
turally and functionally  distinct components. The B subunit 
consists of five identical polypeptides that bind with high 
affinity to GM1 ganglioside cell surface receptors  and facili- 
tate the entry of the A  subunit into the cell (18, 19). CT 
has been widely used because of its strong immunogenicity 
in IgA responses,  and also because  of its capacity to act as 
a mucosal adjuvant for other antigens or vaccines (20-26). 
However, the precise  mechanism for CT adjuvancy in the 
mucosal immune system is not yet understood. 
This work has focused on the Th call subsets  associated 
with optimal IgA responses in mucosal inductive sites (e.g., 
PP) in the GI tract and in the SP of mice orally immunized 
with a protein vaccine in the presence of the mucosal adju- 
vant CT. For these studies, we chose tetanus toxoid (TT) 
as a typical protein vaccine and assessed immunity in both 
T and B cell compartments to both TT and CT. Unlike past 
in vitro studies which suggest that CT inhibits T  cell re- 
sponses, this study has shown that CT facilitates the induc- 
tion of Th2 cell responses to both itself and to coadministered 
antigen (TT) in PP and SP when given orally, but enhances 
both Thl and Th2 responses when administered by the sys- 
temic route. 
Materiah and Methods 
M/c~  C57BL/6 mice that had been barrier maintained  and were 
pathogen-antibody  negative were obtained from the Frederick 
Cancer Research  Facility  (National  Cancer Institute, Frederick, MD) 
at 5-6 wk of age, maintained in horizontal laminar flow cabinets, 
and provided with sterile food and water ad lib. All mice used in 
this study were between 8 and 12 wk of age. 
Immunization of Mice.  Mice  were deprived of food for 2 h and 
given 0.5 ml of a solution containing eight parts HBSS and two 
parts 7.5% sodium bicarbonate by gastric intubation to neutralize 
stomach acidity. After 30 rain, mice were orally immunized by in- 
tubation of  0.25 ml PBS containing  a mixture of  TT (250 #g/mouse) 
kindly  provided by PRAXIS Biologics, Inc. (West Henrietta, NY) 
and CT (10 #g/mouse; Sigma Chemical Co., St. Louis, MO). The 
mice were boosted 1 and 2 wk later. Dose-response and time course 
studies showed that this schedule induced optimal mucosal and 
1 Abbreviations used in  this paper: CT,  cholera toxin; E/C,  experi- 
mental/control;  GI, gastrointestinal;  LP, lamina  propria; LPL,  lamina  propria 
lymphocytes; MLN, mesenteric  lymph nodes; PP, Peyer's patches; KT, 
reverse transcriptase;  SF'C, spot forming  cells; SP, spleen; TT, tetanus  tc0toid. 
serum antibody responses to TT (Jackson, R. J., K. Fujihashi, J. 
Xu-Amano, H. Kiyono, C. D. Elson, and J. R. McGhee, manu- 
script in preparation). Mice  were killed 1 wk after each oral immu- 
nization. For systemic  immunization, mice  were intraperitoneally 
immunized with TT (10 #g/mouse) and CT (1 #g/mouse) or TT 
(10 #g/mouse) only and boosted in the same manner 2 wk later. 
Mice were killed 1 wk after each immunization. Other groups of 
mice were immunized by the intraperitoneal route with TT (100 
#g/mouse) in the presence of  CFA and boosted intravenously  with 
TT (10 #g/mouse) and CT (1 #g/mouse) 4 mo later. Mice were 
killed 1 wk after the booster immunization. 
Detection  of  TT-  and  CT--specific Antibody  Production  by 
ELISA.  Antibody responses were determined by ELISA. Briefly, 
TT (0.08 Lf units/well) or CT-B at 5 #g/ml in PBS was coated 
to Falcon (Microtest III) 96-well assay plates (Becton Dickinson, 
Oxnard, CA) overnight at 4~  Plates were blocked with 1% BSA- 
PBS for 1 h at 37~  Fecal extract samples were obtained by vor- 
texing fecal pellets in PBS as described by others (27). The serum 
and fecal  extracts  were serially  diluted in 1% BSA-PBS and incubated 
for 2 h at 37~  with coating antigens. Detection antibodies con- 
sisting of a 1:1,000 dilution ofbiotinylated goat anti-mouse-#, -% 
or -cx (Southern Biotechnology Associates, Birmingham, AL) in 
PBS with 0.5% Tween-20 (PBS-Tween) were then added to the 
plate and incubated overnight at 4"C. A 1:1,000 dilution of detec- 
tion  enzyme,  horseradish peroxidase-streptavidin (2.5 mg/ml; 
Zymed Laboratories, Inc., South San Francisco, CA) was added to 
the plate and incubated at room temperature for 1 h. The reaction 
was developed by a substrate solution consisting of 1.1 mM 
(2,2' azino-bis [3-ethylbenz-thiazoline-6-sulfonic  acid], diammo- 
nium salt; Sigma Chemical Co.) in 0.05 M citrate-phosphate  buffer, 
pH 4.2, containing 0.01% H2Oz for 15 rain. The developing reac- 
tion was terminated by the addition of 50 #1 per well of 10% SDS 
solution in 0.05 M citrate-phosphate buffer, pH 4.2. Optical den- 
sity was recorded in a plate reader at 414 nm (model EL 312; Bio- 
Tek Instruments, Winooski, VT). End point titers were expressed 
as the last dilution of sample which gave an OD value of >~0.1 
after subtraction of nonimmunized control serum or normal fecal 
extract values (28). 
Preparation of Cell Suspensions  from SP, PP, and Intestinal LB.  SP 
were aseptically  removed  and single cell suspensions were prepared 
as described previously (8, 16, 17). PP were carefully excised from 
the intestinal wall and dissociated using the neutral protease en- 
zyme Dispase  |  (Boehringer Mannheim Corp., Indianapolis, IN) 
in Joklik-modified medium (GIBCO BRL; Gaithersburg, MD) to 
obtain single cell preparations (8,  16, 17). 
Purification Of CD4 + T Cells.  Single  cell suspensions prepared 
from SP were incubated in complete medium consisting of RPMI 
1640 (Whittaker  Bioproducts, Walkersville, MD) supplemented 
with nonessential  amino acids, sodium pyruvate, Hepes, Penicillin, 
streptomycin, gentamycin  (incomplete  medium), and 10% FCS for 
4 h at 37~  5% CO2 in air to remove adherent cells. The CD3 + 
T cells were obtained by negative panning using goat anti-mouse 
Ig F(ab')z in order to avoid T cell stimulation as previously de- 
scribed (15). For enrichment of PP T cells, enzymatically isolated 
PP cells were incubated in complete medium for at least 6 h at 
37~  5% CO2 in air to allow full reexpression of surface mole- 
cules and to remove  adherent cells  before further T cell purification 
by panning with mAb anti-L3T4 as described  elsewhere (15). This 
procedure resulted in  cell fractions containing  >99%  CD4 +, 
CDS-  T cells. 
Antigen-coated Latex Microspheres  for Induction of CD4 + T  Cell 
Responses.  The  proteins TT  and  CT-B were coated  to  latex 
microspheres by a modification of a previously described method 
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~m; Polyscietr.~  In~, Warrington, PA) was washed  and resuspended 
in 4130/zl of 0.1 M bicarbonate buffer (pH 8.8) and TT or CT-B 
(80 ~g/400 ~1) in 0.5 M Tris HC1 buffer (pH 8.0) was slowly added 
with continuous mixing. This suspension  was further diluted with 
400/zl of bicarbonate buffer and then incubated for 24 h at 25~ 
with continuous rocking. The protein-coated microspheres were 
washed twice with sterile PBS, resuspended in RPMI 1640 with 
500 ~ag/ml gentamycin, and incubated for 48 h at 37~  to effect 
sterility. This procedure routinely yielded 0.5 ~g of TT or CT- 
B/10  s beads and represented "~30% of the original sample as de- 
termined by measuring the protein concentration remaining in the 
buffer  phase. CD4 + T  cells (10s/well) were  cultured  in  flat- 
bottom, 96-well microculture plates (Coming Inc., Coming, NY) 
in the presence  of  IL-2 (10 U/rrd), T cell-depleted, irradiated (3,000 
tad) splenic feeder ceils (104-10  s cells/well)  and with different  doses 
of  TT- or CT-B-coated  htex microspheres (particle/cell  ratios of 50:1, 
10:1, and 2:1) or sohble proteins (0.1-10/~g/ml). As controls, wells 
contained cells only or cells incubated with the unrelated antigens 
KLH- or diphtheria toxDid-cuated  htex microspheres. Cultures were 
maintained at 37~  and 5% CO2 in air for various periods (1, 3, 
and  6  d)  and  0.5  /~Ci of [3H]thymidine (Amersham Corp., 
Arlington Heights, IL) was added to all wells 6 h before harvest. 
Cell proliferation was determined by standard liquid scintillation 
counting. The stimulation index E/C (experimental/control) was 
determined in each experiment. 
For analysis  of antigen-specific  Thl and Th2 cell responses, SP 
or PP CD4 + T cells were cultured at a density of 106 cells/m1 to- 
gether with either TT- or CT-B-coated latex microspheres. In ad- 
dition, T cell-depleted, irradiated (3,000 rad) splenic feeder cells 
and IL-2 (10 U/ml) were added to individual cultures. Antigen- 
stimulated T ceils were harvested at various intervals (1, 3, and 
6 d) for the enumeration of cytokine (e.g., IFN-3,, IL-2, IL-4, or 
IL-5) producing cells by use of cytokine-specific  ELISPOT assay, 
and for RT-PCR and Northern blot analysis  of  mRNA expression 
(see below). 
Enumeration of  lFN-% 11.,2-, Ib4-, and llJ5-producing Cells.  The 
ELISPOF assay  was adapted  for cytokine analysis  in antigen-specific 
T cell cultures. For the IFN-3,-specific  ELISPOT assay, mAb anti- 
IFN-3' R4-6A2 (30) and XMG 1.2 (31) were used as coating and 
detection antibodies, respectively,  as described previously (16, 32). 
For measurement of IL-2 specific spot forming cells (SFC) mAb 
anti-mouse IL-2  (CR No. 40014; Collaborative  Research, Inc., Bed- 
ford, MA) was used as the coating antibody, while rabbit IgG 
anti-mouse IL-2 (Collaborative Research, Inc.) was used for detec- 
tion as recently described (33). A similar assay was developed for 
assessment of IL-4-specific SFC with rat mAb anti-mouse  IL-4 
(BVD4-1D11; PharMingen, San Diego, CA) used for coating and 
a biotinylated mAb anti-mouse Ib4 (BVD6-24G2; PharMingen) 
(2/zg/ml) followed by peroxidase-conjugated goat anti-biotin (5 
#g/ml; Vector Labs, Inc.,  Burlingame, CA)  used in detection 
(33). For the elucidation of IL-5-specific SIC, two monoclonal 
anti-mouse IL-5 mAb (TRFK-5 and TRFK-4; 34) were used for 
coating and detection, respectively, as described in our previous 
studies (16, 32). 
Cytokine-specific  Northern Blot Analysis.  For Northern blot anal- 
ysis of cytokine-specific  mRNA present in CD4 + T cell cultures, 
a method described  by others (35, 36) was modified and used here 
(15). Total RNA (20/~g) isolated by the guanidinium thiocyanate 
method (37) from CD4 + T cell culture sample was electropho- 
retically fractionated in 1.2% agarose-formaldehyde  gels and then 
stained with ethidium bromide to ensure  the quality of  RNA loaded 
and to localize the ribosomal RNA. The separated  RNA was then 
transferred to nitrocellulose transfer membranes (Micron Separa- 
tions Inc., Westboro, MA) and UV cross-linked. Blots were pre- 
hybridized at 42~  in 5x  SSC containing 0.1% SDS, 50 mM 
NaHzPO4, 50% formamide, 10 mM Na4P2Os, 5 x  Denhardt's so- 
lution, and 250 #g/ml sonicated salmon sperm DNA for 6 h. 
Hybridizations were carried out at 42~  in the same solution with 
the addition of 3zp-hbeled cDNA for mouse IFN-3,, IL-2, IL-4, or 
Ib-5 (Clontech Laboratories, Palo Alto, CA) and reacted for 48 h. 
Blots were washed sequentially (twice in each step) using 2 x SSC 
and 0.1% SDS for 20 min at 42~  followed by more stringent 
washes with 0.2￿  SSC and 0.1% SDS for 20 min at 42~  Blots 
were exposed to x-ray film (Eastman Kodak Co., Rochester, NY) 
for 96 h and then developed. The total RNA preparations were 
also hybridized with an actin-specific  cDNA probe as an internal 
control for each blot. 
Cytokine-specific PC,  R Analysis.  RT-PCR analysis  was also used 
to detect IFN-3,, Ib2, IL-4, and IL-5 mKNA expression. Briefly, 
SP or PP CD4 § T calls were washed twice with PBS and total 
cytoplasmic  RNA was extracted from the cells using vanadyl ribo- 
nucleoside  complexes as an RNase inhibitor (38). Reverse transcrip- 
tion was carried out using oligo (dT)16 primer and the specific 
cDNA fragment was amplified  by using RT-PCR (39). The IL-2, 
IFN-% and IL-4 primers used for amplifcation during the PCR 
were obtained from Clontech Laboratories. The sequences used 
for IL-5 primers were: sense: 5' ATGACIGIGCCTCTGTGCCTG- 
GAGC 3  ~ antisense: 5' CTGTTTTTCCTGGAGTAAACTGGGG 
3' (40). To verify that equal amounts of RNA were added in each 
RT-PCR reaction, primers for fl-actin mRNA were used to am- 
plify the cDNA reverse transcribed from the total RNA. To detect 
the amplified products, a total of 10 #1 of the final reaction mix 
was run on a 2% agarose gel at 100 V for 2 h. The gels were then 
stained with ethidium bromide (0.5 #g/ml), visualized  under UV 
light, and photographed. To ensure the specificity  of  the PCR prod- 
ucts, the gels containing amplified  IL-2, IL4, IL-5, and IFN-3, PCR 
product were Southern blotted to nitrocellulose membranes (Mi- 
cron Separations  Inc.) and hybridized  with the appropriate cytokine- 
specific cDNA probes. Single bands that corresponded with the 
size of the PCR products were detected for all cytokines tested. 
Results 
Anti-TT and-CT-speci.fic Antibody Responses.  We first de- 
termined the oral dose and number of immunizations required 
for maximum anti-TT and -CT antibody responses in serum 
and in GI tract secretions.  We have shown that mice orally 
immunized with 250/zg of TT and 10/~g of CT three times 
at weekly intervals gave maximum IgA anti-TT and -CT 
responses on day 21 in fecal samples (1:128 for TT and 1:512 
for CT). Further, serum IgG anti-TT and -CT antibody re- 
sponses were also highest with this regimen (1:131,000 and 
1:1,048,000,  respectively).  As a comparison, mice systemi- 
cally immunized with TT and CT contained serum TT- 
specific IgM (1:4,000) and IgG (1:32,000) antibodies 7 d after 
the first immunization and markedly increased IgG (but not 
IgA) responses  (fourfold) 1 wk after boosting. Again, CT 
was necessary for induction of these antibody responses, since 
mice systemically immunized with TT alone showed 65-fold 
lower TT-specific IgG responses in serum 1 wk after boosting. 
Thus, we chose to assess Th cell subsets  in PP and SP cell 
cultures during peak antibody responses. 
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Figure  1.  Antigen-specific CD4 + T cell proliferative responses in PP and SP of orally immunized mice (A) and in SP of systemically immunized 
mice (B). Mice were immunized by gastric intubation with TT (250 #g/mouse) plus CT (10/~g/mouse)  and reimmunized 1 and 2 wk later. As control, 
mice were immunized by the intraperitoneal  route with 0.5 ml of TT (100/~g/mouse)  in CFA and boosted  intravenously  with TT (10/~g/mouse) 
and CT (1/~g/mouse) 4 mo later.  1 wk after the last immunization, mice were killed and CD4 + T cells were isolated from PP and SP and cultured 
at a density of 10  s cells/well in vitro with TT-coated latex microspheres at different bead to cell ratios (2:1 to 50:1) or with soluble TT (0.1-10/~g/ml) 
in the presence of Ib2 and different  numbers  of feeder cells (104 or 10  s cells/well).  6 h before cell harvest,  0.5 #Ci of pH]thymidine was added  to 
each well. The proliferative responses of CD4 + T cells after 3 and 6 d in culture were measured by assessing the amount of pH]thymidine incorpora- 
tion. The results are expressed as stimulation  index E/C (nonstimulated  cells from naive mice).  Control cultures  ranged  from 140 to 300 cpm. 
Characterization  of  TT-specific  T  Cell  Proliferative Re- 
sponses.  To examine antigen-specific T cell responses in vitro, 
CD4 + T  cells were isolated from PP and SP of mice that 
had received three oral immunizations with TT plus CT at 
weekly intervals and from SP of mice initially immunized 
with TT in CFA, and boosted intravenously with TT and 
CT. CD4 + T  cells were cultured in weUs containing feeder 
cells (either 1  x  10g/well or 1  x  10S/well) in the presence 
of different doses of TT-coated latex mierospheres or TT in 
solution (Fig. 1). After 3 and 6 d of incubation, T ceU prolifer- 
ative responses were measured by [3H]thymidine incorpora- 
tion (Fig.  1). PP and SP CD4 + T cells from mice orally im- 
munized with TT plus CT responded vigorously to TT (Fig. 
1 A). In this regard, stimulation indices of up to 74-fold were 
noted when PP CD4 + T call cultures were stimulated with 
TT-coated latex mierospheres. High E/C indices were always 
induced by TT coupled to latex mierospheres when com- 
pared with TT in solution.  TT-coated latex microspheres 
also gave significant  stimulation indices for SP CD4 + T  cells 
from the mice intravenously immunized with TT plus CT 
(Fig. 1 B). The addition of unrelated antigens (KLH- or diph- 
theria toxoid-coated latex microspheres)  to cultm~ containing 
CD4 + T cells from TT- plus CT-immunized mice resulted 
in minimum  stimulation  (less  than twofold). A  10:1 ratio 
of TT-coated latex microspheres to CD4 + T  cells gave op- 
timal T cell stimulation indices in 6-d cultures (Fig.  1). Fur- 
thermore, CT-B-coated latex microspheres at a bead to cell 
ratio of 10:1 also gave significant  stimulation  of CD4 + T 
cells from mice orally or systemically immunized with TT 
plus CT (data not shown). Thus, antigen-specific  CD4 + Th 
cell proliferative responses were induced by stimulating the 
Th cells with TT-coated latex microspheres, and the optimal 
in vitro conditions for TT-specific CD4 + T  cell responses 
were shown to be a  10:1 ratio  of mierospheres to T  cells. 
1312  Oral TT and CT Adjuvant Induces  Ag-specific Th2 Cells and IgA Responses A  Th2 Type Cytokines 
Antigen used 
in vitro  IL-4  IL-5 
m 
Days in culture 
Thl Type Cytokines 
IFN-y  IL-2 
CT-B  ,  I  1 
El  6 
0  too  200  0  1oo  200  0  too  2o0 
Numbers of SFC / 10  3 Cells 
1oo0  200 
B 
An4kpn.md 
In vitro 
TT 
Th2 Type Cytok,nu  Thl Type Cytoklnee 
IL4  IL-S  Days  in culture  I  FN-y  IL-2 
/ 
J 
CT-B 
m 
I 
| 
O  1OO  1OO  0  1OO  16o 
Numbers of SFC / 10  3 Cells 
Figure  2.  Oral immunization of mice induces TT- 
and CT-B-specific, IL.4- and IL-5-producing Th2 cells 
in PP (A) and SP (B). Mice were orally immunized 
as described in the legend to Fig.  1.  1 wk after the 
third oral immunization, mice were killed and PP and 
SP CD4 + T cells were isolated and stimulated in vitro 
with TT- or CT-B-coated latex microspheres under op- 
timal conditions  (see Results).  Control cultures were 
not pulsed with Ag-coated microspheres. At various 
culture intervals  (days 1,  3,  and  6),  CD4 + T  cells 
were assessed for the numbers  of IFN-% IL-2, II:4, 
and  II.-5 SFC by cytokine-specific ELISPOT assays. 
Antigen-specific cytokine~producing cells are calculated 
as the numbers of SFC in antigen-stimulated  cultures 
after subtraction  of the number of SFC in control cul- 
tures. The results are presented as the mean antigen- 
specific cytokine  SFC  _+  1 SE. 
Oral Immunization with TT in the Presence of CT Adjuvant 
Preferentially Induces IL-4- and IL-5-producing Th2-Type Cells 
in PP and SP.  We next determined the nature of Thl and 
Th2 cell responses induced by oral immunization of  mice with 
TT plus CT. The CD4 + T cells were purified as described 
above and then cultured with either TT- or CT-B-coated latex 
microspheres. At various intervals (1, 3, and 6 d), the numbers 
of IL-2-, IFN-3,-, IL-4-, and IL-5-producing  cells were de- 
termined by respective cytokine-specific  ELISPOT assays (Fig. 
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2). The frequency of antigen-specific  IL-4- and IL-5-producing 
cells increased with time in culture, while IL-2 and IFN-3' 
SFC were the same as background (Fig. 2). The predomi- 
nance of Th2-type responses was maintained throughout the 
culture period and the numbers of IL-4 and IL-5 SFCs were 
generally higher in PP than in SP. 
Further, when mice were orally immunized with TT only, 
low numbers of IL-2,  IFN-%  IL-4-,  and IL-5-producing 
CD4 + T  cells were seen (Fig. 3).  After in vitro antigen stimulation, significant numbers of IL-4- and IL-5-producing 
Th2-type cells were seen when compared with IFN-~- or 
IL-2-producing  Thl-type cells. However, much higher fre- 
quencies of Th2 cytokine-producing cells were found in PP 
CD4 + T cell cultures from mice orally immunized with TT 
plus CT (Fig. 3). This finding indicates that CT is impor- 
tant for induction of higher TT-specific Th2-type responses 
in orally immunized mice. Taken together, these results show 
that oral immunization preferentially induces antigen-specific 
Th2-type cells in PP and SP. 
Analysis of Cytokine-specific mRNA.  To determine whether 
the induction of Th2 cell responses by oral immunization 
with TT plus CT resulted from increased mRNA produc- 
tion, we assessed cytokine~specific  mRNA expression  by using 
Northern blot analysis with IL-2-, IFN-3,-, IL-4-, and IL-5- 
specific cDNA probes (Fig. 4). The results of the mRNA 
analyses correlated well with the ELISPOT assay. High levels 
of a 1.5-kb IL-5 message were detected in both PP and SP 
CD4 + T cell cultures from mice orally immunized with TT 
and  CT  and  stimulated  in  vitro  with  TT-coated  latex 
microspheres, with higher levels noted in the PP T cell cul- 
tures. Significant amounts of 2.0-kb IL-4 message were also 
found in PP and SP CD4 + T  cell cultures.  On the other 
hand, no signals for IL-2 or IFN-~/were seen in PP or SP 
CD4 § T cell cultures while 13-actin mRNA levels remained 
the same in all cultures (data not shown). These findings fur- 
ther support the cytokine-specific ELISPOT results and indi- 
cate that de novo synthesis of Th2-specific cytokine mRNA 
occurs in antigen-stimulated T  cell cultures. 
Since our results suggested that oral administration of the 
protein TT together with CT led to increased expression of 
cytokine-specific  mRNA and synthesis of Th2-type cytokines, 
it was important that more sensitive methods be used to 
confirm this result. Accordingly,  we have used cytokine-spedfic 
RT-PCR analyses to determine the cytokine mRNA expres- 
sion in PP and SP CD4 + T cell cultures. A 243-bp band that 
corresponded to IL-5-specific RT-PCR product was consis- 
tently seen in RNA preparations obtained from both PP and 
SP CD4 + T cells of orally immunized mice (Fig. 5), and in 
vitro stimulation with TT-coated microspheres resulted in 
marked increases in IL-5-specific mRNA. The IL-4 mRNA 
expression was weak in PP CD4 + T cells at day 0; however, 
after in vitro stimulation, increases  in IL-4 mRNA were noted 
in  PP  CD4 + T  cells (Fig. 5).  Interestingly,  IL-4-specific 
mRNA was low but detectable in SP CD4 + T cells stimu- 
lated in vitro, and this is probably due to the low numbers 
of IL-4-producing T cells present in SP when compared with 
PP.  In other studies, we could detect IL-4 mRNA in SP 
CD4 + T cell cultures stimulated with TT by using higher 
numbers of amplifying cycles  in RT-PCR. This sensitive  PCR 
amplification method did not allow detection of either IL-2 
or IFN-qr-specific mRNA in SP or PP CD4 + T cells from 
mice orally immunized with TT in the presence of CT (day 
0) (data not shown). After in vitro antigen stimulation, IFN-'p 
or IL-2-specific mRNA expression remained undetected in 
PP or SP CD4 + T  cells (days 3 and 6; data not shown). 
These results dearly show that oral immunization preferen- 
tially induces antigen-specific Th2-type responses in mucosal 
inductive sites (e.g., PP) and probably accounts for the IgA 
responses associated with effector tissues (e.g., LP). 
Kinetics of T Cell Responses after Oral Immunization.  To 
study the antigen entry and T  cell priming process in PP 
after oral immunization with TT and CT, we next performed 
the T cell proliferation  assay for PP and SP CD4 + T  cells 
isolated from mice orally immunized with TT and CT at 
days 0, 7, and 14 and determined the frequency of Thl- and 
Th2-type cytokine-producing cells. PP and SP CD4 + T cells 
from mice I and 2 wk after initial oral immunization responded 
weakly to antigen stimulation; however, 1 wk after the third 
booster immunization (day 21), maximum proliferative re- 
sponses were observed in day 6 PP and SP CD4 + T cell cul- 
tures (Fig. 6 A). Further,  cytokine-specific ELISPOT assays 
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Figure 3.  Oral immunization  of mice with TT and 
CT selectively  upregulates Th2 responses to TT. Mice 
were immunized  by gastric intubation with TT (250 
/~g/mouse) plus CT (10/zg/mouse)  or with TT (250 
/zg/mouse) only at days 0, 7, and 14. I wk after the 
last  oral  immunization, mice  were  killed  and PP 
CD4 + T cells were isohted and cultured in vitro with 
TT-coated htex microspheres  under optimal conditions 
(see Results). Control cultures were not pulsed with 
TT-coated or received  KLH-coated htex microsphe~s. 
After 6 d of culture, CD4 + T cells were assessed for 
the numbers of IFN-% IL-2, IL-4, and I1-5 SFC by 
cytokine-specitic ELISPOT  assays. The  results  are 
presented as the mean antigen-specific cytokine SFC 
_+  1SE. 
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kine-specific  mRNA  expression  by 
Northern blot analysis in mice orally 
immunized with TT  plus  CT.  Mice 
were orally immunized with TT and 
CT as described in the legend to Fig. 
3. Mice were killed I wk after the last 
oral  immunization  and  PP  and  SP 
CD4 + T cells were isolated and stimu- 
lated  in  vitro  with  TT-coated  latex 
microspheres in the presence of Ib2 and 
SP feeder cells. Total RNA was isolated 
from both PP and SP CD4 + T cells at 
the time of sacrifice (day 0) and at the 
end of in vitro stimulated cultures (day 
6).  The RNA was then subjected  to 
Northern blot analysis by hybridization 
with mouse IFN-% Ib2, IL-4, and Ib5 
cDNA probes to determine the amount 
of specific  cytokine mRNA expression. 
Positive controls were RNA from SP 
cells stimulated  with Con A for 20 h. 
showed that PP and SP CD4 + T  cells isolated from mice 
7 and 14 d after oral immunization did not contain significant 
numbers of IL-4- or IL-5-producing Th2-type cells, nor did 
they possess high levels of IL-2 or IFN-~/-secreting Thl-type 
cells (Fig. 6 B). However, by day 21 (i.e., after three oral doses) 
we could detect a high frequency of IL-4- and IL-5-producing 
Th2-type cells in PP and SP CD4 + T  cell cultures with 
higher numbers noticed in PP CD4 + T cell cultures. These 
results clearly indicated that three oral immunizations with 
TT and CT were required to induce maximum antigen-specific 
Th cell responses, namely, Th2 cell responses in PP. This cor- 
related with the antigen-specific antibody responses where 
we see maximum TT-specific IgA responses in the intestine 
at day 21 of immunization. 
Systemic Immunization with TT and CT Induces Both IL-4-, 
IL-5-producing Th2-Type Cells and IL-2-, IFN-7-secreting Thl- 
type Cells in SP..  To determine the possible role of CT in 
directing Th cell responses into a particular Th cell pathway, 
we have determined the type of Th cell responses in SP of 
mice intraperitoneally  immunized with TT alone or with 
TT plus CT. SP CD4 + T cell cultures established from mice 
I wk after primary or booster immunization with TT only 
or with TT plus CT contained both IL-4- and IL-5-producing 
Th2-type cells and IL-2- and IFN-3' secreting Thl-type cells. 
Figure  5.  Levels  of IL-4 and I1--5 mRNA expression in PP and SP CD4 + T cells from mice orally immunized with TT plus CT. Mice were given 
TT and  CT orally as indicated  in the legend to Fig.  1. Mice were killed and  PP and SP CD4 + T  cells were isolated  and stimulated  in vitro with 
TT-coated latex microspheres  as described in Materials and Methods.  At various culture intervals (days 0, 3, and 6) total RNA was extracted  and the 
levels of 1I.-4 and  IL-5 mRNA expression  were determined by RT-PCR using cytokine-spedfic  primers. 
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Figure  6.  Kinetics  of Th cell responses after oral 
immunization.  Mice were orally immunized as de- 
scribed in Fig. 1, and 7, 14, and 21 d after immuniza- 
tion mice were killed. The PP and SP CD4 + T cells 
were isolated and stimulated  in vitro with TT-coated 
latex microspheres  for the determination of Th cell 
proliferative responses at 3 and 6 d of cultures (A) and 
the numbers of Thl- and Th2-type cytokine~producing 
cells at 6 d of culture (B) as described in the legends 
to Figs. 2 and 3. Results are expressed as stimulation 
index E/C (21) and the mean antigen-specific cytokine 
sPc  _+  ~ SE (8). 
Higher frequencies of both Thl- and Th2-type cells were 
seen in mice immunized with TT plus CT.  This finding 
showed that CT also acted as an adjuvant at the Th cell level 
for antigens coadministered systemically with CT (Fig. 7). 
This result also indicated that it is not the CT that directs 
the Th cell responses, but rather, the route of  immunization. 
While both Thl- and Th2-type cells were induced in SP by 
systemic administration of  TT plus CT, the oral route of im- 
munization predominantly induced Th2 cells in mucosa- 
associated tissues. 
Discussion 
A major goal of our research has been to characterize the 
nature of Th cells and derived cytokines for induction of B 
cells to become IgA-producing plasma cells in mucosal effector 
sites. Therefore, in this study we used the well-characterized 
protein vaccine, TT, and CT as an adjuvant  in the mouse 
model, since it has been shown that oral administration  of 
microgram amounts of CT resulted in substantial serum and 
mucosal antibody responses to CT itself and to coadministered 
proteins (20-26). However, it has remained unclear whether 
immune responses were first induced in PP, followed by an 
exodus of immune B and T  cells to mucosal effector sites, 
or whether CT enhanced immune responses directly in the 
LP of the GI tract. This study would strongly argue that 
oral immunization with TT and CT induces both T and B 
cell responses in the PP. In vitro culture of PP CD4 + T cells 
with either TT- or CT-B-coated  microspheres resulted in 
significant T cell proliferative responses, suggesting that di- 
rect antigen uptake and immunization occurred in the PP 
itself.  On the other hand, stimulation of CD4 + Th cells 
from PP of nonimmunized mice with TT-coated microspheres 
induced minimal proliferative responses (data not shown). 
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Figure 7.  Systemic  immunization  with TT and 
CT induces both Ib4- and lb5-producing Th2- 
type cells and Ib2- and IFN-~/-secreting Thl-type 
cells in SP.  Mice were  immunized by the in- 
traperitoneal route at days 0 and 14 and were killed 
at either day 7 (primary) or day 21 (booster). The 
SP CD4 §  T  cells were isolated and stimulated 
with TT-coated late~ microspheres for 6 d, and the 
numbers of Ib4-, IL-5-, IL-2-, and IFN-~/-pro- 
ducing cells were determined by using cytokine- 
specific ELISPOT assays. The results are presented 
as the mean antigen-specific  cytokine SFC +_ 1 SE. 
We adapted a protein-coated  microsphere method to in- 
duce CD4 + T  cell responses in  vitro.  This method was 
significant for these analyses since soluble antigens are some- 
times  poor  stimulants  for  T  cells and  are  suboptimally 
processed by APCs,  especially in mucosa-associated tissues 
(41). Our results are the first to show that TT-coated latex 
microspheres induced significant proliferation  of CD4 + T 
cells from mice orally immunized with TT and CT, and al- 
lowed detection of  individual cytokineoprodudng T cells. The 
results obtained in this study have shown that oral immuni- 
zation with TT and CT preferentially induced IL-4- and IL- 
5-producing, TT-specific Th2-type cells in PP CD4 + T cell 
cultures. This result contrasted with our previous study with 
SRBC, where it was shown that although predominant Th2 
cell responses were induced, significant Thl cell responses 
were seen (17). In the present study, we showed that specific 
IgA antibody responses from mice orally immunized with 
TT plus CT correlate with a preferential Th2 cell response 
in PP and SP. 
Other groups  have studied cytokine production in vitro 
using lymphoid cells isolated from SP, mesenteric lymph nodes 
(MLN), PP, and LP of mice orally immunized with KLH 
and CT (42). For example, high levels of IL-4, IL-5, and IL-6 
with lower levels of IL-2 and IFN-~/were seen in lamina 
propria lymphocyte  (LPL) cultures, while PP gave lower Th2- 
type cytokines when compared with LPL cultures. The IL-2 
levels were similar in PP and LPL, while low levels of IFN-3, 
were present in PP (42). In our studies, by using the cytokine- 
specific  ELISPOT assay, we were able to show that the numbers 
of antigen-specific IL-4- and IL-5-producing  cells could be 
enhanced by antigen restimulation in vitro; however, essen- 
tially no antigen-specific IFN-'y- or IL-2-producing Thl-type 
cells were noted. Our experiments also differed from the other 
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study (42) which used whole LPL populations that contained 
other cell subsets in addition to CD4 § T  cells. Thus, we 
used purified CD4 + T cells to ensure that the antigen effects 
noted were due to direct stimulation of T cells and not to 
stimulation of other cell types that could influence  the cytokine 
pattern observed. Further, since no mKNA analyses  were car- 
ried out in the earlier study (42), it remained to be estab- 
lished that the effect of oral immunization and in vitro an- 
tigen stimulation induced antigen-specific  Th cells to produce 
cytokines de novo. Good correlations were noted in our studies 
between the numbers of cytokine-specific cells and the levels 
of cytokine mKNA expression and clearly indicated  that 
antigen-specific Th2 cell responses were induced by oral im- 
munization with TT and CT. Therefore, the increase in Th2- 
type cytokine-producing cells was probably a direct conse- 
quence of increased Th2 cytokine mKNA expression. 
An interesting result was found when SFC and mlLNA 
levels for IL-4 and IL-5 were determined in CD4 + T  cell 
cultures from PP and SE The numbers of IL-4- and IL-5- 
producing cells were generally lower in SP than in PP CD4 + 
T  cell cultures.  Further, we could detect only weak IL-4 
mRNA expression by PCK in SP CD4 + T  cell cultures 
from mice orally immunized with TT and C~ however,  under 
the same conditions IL-4 mRNA was higher in PP CD4 + 
T  cell cultures.  On the other hand, we could detect IL-5 
mRNA in both PP and SP CD4 + T  cell cultures.  These 
results suggest that orally primed TT-specific Th2-type cells 
in PP probably migrate to SP before residence in the LP of 
the GI tract.  Further, under the influence of a particular 
microenvironment, IL-4 expression is low for Th2 cells in 
SP for reasons that are not yet understood. It is tempting 
to speculate that decreased  IL-4 production is a necessary  char- 
acteristic for T cells that temporarily reside in the spleen be- fore  migration  to  effector  sites. This  would  avoid the 
nonspecific activation of mature splenic B cells and prevent 
their terminal differentiation  in this  site. 
Although CT has been shown to be a potent oral adju- 
vant, the precise mechanism for adjuvancy in the mucosal 
immune system is not yet understood.  The results from in 
vitro studies with isolated T and B cells and APC suggest 
that CT can affect all of the cell types involved in the induc- 
tion of antigen-specific immune responses (43, 44). In this 
regard,  CT has been shown to promote isotype-switching 
of LPS-stimulated surface IgM-bearing B cells to expression 
of IgG or IgA (44). CT can act synergistically with IL-4 to 
promote switches to the IgG1 subclass and subsequent differen- 
tiation to IgG1 synthesis in LPS-stimulated B cell cultures 
(45). CT can inhibit some T cell functions,  including IL-2 
production and IL-2-dependent proliferation  (46, 47). Fur- 
ther, CT stimulates IL-1 production and antigen presenta- 
tion by macrophages (48). Other studies (49) showed that 
rCT-B enhanced the expression of MHC class II molecules 
and minor lymphocyte-stimulating  determinants on B cells. 
However, the exact mechanisms for CT adjuvant activity at 
the level of antigen-specific Th cells, including Thl and Th2 
cell responses to orally administered protein-based vaccines, 
have not been elucidated. 
The studies of others (50) have shown that CT inhibited 
T cell receptor-mediated  IL-2 production and proliferation 
in Thl cells while it failed to block IL-4 production and 
proliferation in Th2 cells. Since CT led to elevated levels of 
intracellular cAMP, it was concluded that CT discriminates 
between Thl and Th2 cells in TCR-mediated activation (50). 
Our results of preferential induction of  Th2-type cells by oral 
immunization with TT and CT as adjuvant could be used 
as evidence for this hypothesis. However, other factors may 
also determine the nature of  Th cell responses. Recent reports 
indicate that CT may influence cellular growth via cAMP- 
independent mechanisms (51-54). It should be emphasized 
that the results that support the hypothesis that CT blocks 
IL-2R expression on Thl cells were obtained from the study 
of only two long-term T cell clones, one for Thl- and the 
other for Th2-type responses (50). In this study, we have com- 
pared the type of Th ceil responses induced by systemic pri- 
mary and booster immunization with TT only or with TT 
plus CT. The results showed that systemic  immunization with 
TT only or with TT plus CT induced both Thl- and Th2- 
type cells in SP of primary or booster immunized mice. On 
the other hand, predominant Th2 cell responses were always 
seen in mice orally immunized with TT only (Fig. 3). When 
CT was coadministered with TT, this enhanced Th2 cell re- 
sponses and represents one mechanism for CT adjuvant ac- 
tivity at the level of Th cells. This would suggest that the 
route of immunization and the innate features of PP, e.g., 
specialized antigen uptake and unique APCs, are important 
for Th2 cell responses and that  CT  is  less important in 
modulating specific types of Th cell responses. 
In conclusion, oral immunization with TT and CT as ad- 
juvant induces antigen-specific  Th2 cells in mucosa-associated 
tissues and this has significant implications in the develop- 
ment of oral vaccines. Studies for the evaluation of mucosal 
vaccines should include analysis of IgA antibody responses 
as well as Th cell responses since the T cell-derived cytokines 
significantly influence the isotype and level  of  B cell responses. 
Our results provide the first compelling evidence that high 
titers of IgA antibodies directly correlate with the presence 
of antigen-specific Th2-type cells. Since antigen-specific Thl 
cells were either absent or below the level of detection by 
the methods used here, this would for the first time argue 
that Thl-type cell responses  are not required for mucosal S-IgA 
immune responses. This may indicate  that  IgA anti-pro- 
tein/vaccine responses are totally Th2 cell dependent;  that 
is, to obtain optimal mucosal IgA responses, Th2 cell responses 
are required. To further test this idea, we are currently deter- 
mining the type of Th cell responses in mice treated with 
either  anti-IFN-3',  anti-IL-4,  or  anti-IL-10  followed  by 
challenging with TT together with CT to determine whether 
anti-cytokine treatment can alter Thl and Th2 cell responses 
and thus affect  antigen-specific  IgA antibody responses to both 
TT and CT in the GI tract. 
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